Executive Summary
Across 33 filings from NASDAQ-100 related entities, proxy statements dominate (18/33) signaling peak annual meeting season in May-June 2026, with positive executive comp and achievements in biotech/tech (e.g., Immunome exceeded targets 145-150%, Alphabet Gemini launch). Q1 2026 financials show semis rebounding (Intel rev +7.2% YoY to $13.6B, TI +18.6% to $4.8B) amid CHIPS incentives, but mixed elsewhere: telecom softness (Charter rev -1% YoY), coal disruptions (Alpha Met Q1 loss $11M), and sharp declines (ILAG rev -40.1% YoY). Capital returns strong (Comcast $11.7B buybacks/divs reducing shares 5%, TI $1.29B divs), with biotech funding wins (Altimmune $211M for Phase 3 MASH trial). Portfolio trends: Revenue growth avg +10% YoY in reporting cos (5/7), but losses prevalent (Intel $3.7B net loss, Blue Moon $38.8M); positive sentiment 12/33, mixed 10/33. Key implications: Watch proxy votes for equity plan approvals adding shares (Alphabet 200M Class C), semis for foundry ramps, biotechs for catalysts.
Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from April 17, 2026.
Investment Signals(11)
- Immunome Inc.↓(BULLISH)▲
Exceeded non-equity incentives 145-150% of targets (Development 60% wt exceeded), CEO base +5% YoY to $735k, new 800k options grant
- Alphabet Inc.↓(BULLISH)▲
2025 achievements incl Gemini 3 launch, Ironwood TPU, new Risk Committee; proposing 200M Class C shares for 2021 plan at June 5 AGM
- AITX(BULLISH)▲
Secured 16-unit ROSA order for multi-site construction, signaling AI security demand growth
- Intel Corp.↓(BULLISH)▲
Q1 rev +7.2% YoY to $13.6B (Foundry +16.2%, DCAI +22.5%), gross profit +14.5%, cash +20% YoY to $17.7B despite restructuring
- Altimmune Inc.↓(BULLISH)▲
Closed $211M net proceeds offering for pemvidutide Phase 3 MASH trial, warrants extend to 5yrs post-data
- Comcast Corp.↓(BULLISH)▲
2025 rev $123.7B, Adj EBITDA $37.4B, $11.7B returns (buybacks $6.8B cut shares 5%), Peacock subs +22% to 44M
- Keurig Dr Pepper↓(BULLISH)▲
2025 net sales +8% const curr, Adj EPS +7%, pro forma rev ~$28B post-JDE; planning tax-free split
- Texas Instruments↓(BULLISH)▲
Q1 rev +18.6% YoY to $4.8B (Analog +22.3%), NI +31% to $1.5B, op cash +79% to $1.5B w/ $555M CHIPS
- Texas Community Bancshares↓(BULLISH)▲
Q1 NI +30% YoY to $836k (6th record qtr), NII +3.1%, nonint inc +51.1% despite loans -1.6% QoQ
- Genco Shipping↓(BULLISH)▲
Rejected $23.50/share bid (undervalues vs $25 NAV), Q4 2025 EBITDA/TCE highs, $323M divs over 6yrs (247% TSR vs S&P 76%)
- OptimumBank Holdings↓(BULLISH)▲
Q1 NI +20.5% YoY to $4.7M, deposits/loans +17.3%/+13.8% QoQ to $1.09B each, assets +$157M QoQ
Risk Flags(7)
- Intel Corp./Earnings↓[HIGH RISK]▼
Q1 op loss $3.1B (vs $301M prior), net loss $3.7B due to $4.1B restructuring; assets -3% QoQ to $205B
- Charter Communications/Revenue↓[MEDIUM RISK]▼
Q1 rev -1% YoY to $13.6B (video -9.1%, internet -1.3%), NI -4.5% to $1.2B despite buybacks
- Blue Moon Metals/Losses↓[HIGH RISK]▼
FY25 net loss $38.8M (+7728% YoY), expl exp +7188% to $32.7M, cash burn ops $29.6M despite assets +685%
- Intelligent Living App/Financial Health↓[HIGH RISK]▼
FY25 rev -40.1% YoY to $4.5M, op exp +276% to $19.5M, net loss to $19.3M; going concern doubt, assets -41%
- Alpha Met Resources/Operations[MEDIUM RISK]▼
Q1 net loss $11M, Adj EBITDA $30M on lower shipments/terminal outage, cash costs +$107.98/ton (met margin $16.41)
- Federal Home Loan Bank SF/Profitability[MEDIUM RISK]▼
Q1 NI -32% YoY to $64M (non-int inc -23M), assets -3.5% to $70.7B, exp +19% on contributions
- Intuitive Machines/Exec Change↓[LOW RISK]▼
N/A but proxy context w/ recent acqs; monitor post-KinetX/Lanteris integration risks
Opportunities(8)
- Altimmune/Phase 3 Funding↓(OPPORTUNITY)◆
$211M net for pemvidutide MASH pivotal trial + pre-commercial; warrants to 5yrs post-data readout
- Intel Foundry(OPPORTUNITY)◆
Q1 +16.2% YoY to $5.4B, cash +20% YoY; CHIPS tailwinds position for semis recovery vs peers
- Comcast Capital Returns(OPPORTUNITY)◆
$11.7B to shareholders in 2025 (highest FCF history), wireless +1.5M lines; Peacock EBITDA loss cut $700M
- Texas Instruments/Geography↓(OPPORTUNITY)◆
Q1 rev +18.6% YoY, US 37%/China 21%; capex -40% YoY to $676M signals efficiency
- Genco Shipping/Proxy Fight↓(OPPORTUNITY)◆
Strong drybulk mkt, $0.50 div (26th qtr), rejecting undervalued bid; vote white card June AGM
- KDP/Split(OPPORTUNITY)◆
Tax-free separation into 2 cos post strong 2025 (+8% sales); Rafael Oliveira new Coffee CEO
- AITX/Order Momentum(OPPORTUNITY)◆
16 ROSA units for construction sites; AI security demand in multi-site deployments
- Blue Moon Metals/Growth↓(OPPORTUNITY)◆
Assets +685% YoY to $254M via Nussir/NSG acqs, cash $92.8M; copper/zinc ramp potential
Sector Themes(5)
- Proxy Season Peak(THEME)◆
18/33 filings proxies/DEFA (Alphabet, Acadia, KDP, etc.), AGMs May29-June16; watch equity plan votes (Alphabet +200M shares, Acadia +5.2M) for dilution
- Semis Revenue Rebound(THEME)◆
Intel +7.2% YoY, TI +18.6% (Analog +22%), op cash surges (Intel +35% QoQ, TI +79%); CHIPS $555M boosts vs flat R&D
- Biotech Comp/Orders Positive(THEME)◆
Immunome bonuses 145-150% targets, Altimmune $211M raise, AITX order; 6/10 biotech/neutral-positive sentiment
- Telecom/Coal Softness(THEME)◆
Charter rev -1% YoY (video -9%), Alpha Met Q1 loss on outages; 3/5 mixed/neg w/ cost pressures (Alpha costs +$108/ton)
- Capital Returns Robust(THEME)◆
Comcast $11.7B (shares -5%), TI div $1.29B Q1, Genco $323M 6yrs, Alpha $17.5M buybacks; prioritizing shareholders amid mixed earnings
Watch List(8)
June 5, 2026 vote on 200M Class C shares, auditors, comp; Risk Committee for AI regs [WATCH June 5]
May 29, 2026 virtual; approve 5.2M share increase in 2024 plan, record Apr14 [WATCH May 29]
Definitive Q1 results May 8, 2026 call 10am ET; terminal outage impacts, liquidity $476M [WATCH May 8]
AGM vote vs Diana nominees; $23.50 bid rejection, strong divs [WATCH June 2026]
CAO Scott Gawel resigned Apr24, CFO Zinsner interim; Q1 loss context [WATCH Q2 earnings]
- KDP/AGM & Split👁
June 16, 2026; tax-free separation plans, strong 2025 growth [WATCH June 16]
June 10, 2026 virtual; director election, auditors ratify [WATCH June 10]
June 12, 2026; post 1:40 reverse split Apr13, plan share increase [WATCH June 12]
Filing Analyses(33)
24-04-2026
Immunome Inc.'s 2025 proxy statement discloses executive compensation for Named Executive Officers, including base salaries of $735,000 for CEO Clay Siegall (5% YoY increase), $472,500 for CFO Max Rosett, and $530,300 for CMO Robert Lechleider. Annual non-equity incentives exceeded targets, with payouts of $661,500 (150% of target) to Siegall, $278,800 (148%) to Rosett, and $307,600 (145%) to Lechleider, driven by exceeding goals in development (60% weighting), research (15%), and stretch objectives, while achieving targets in operations, business development, and commercial areas. New 2025 equity grants included 800,000 stock options to Siegall, 207,000 to Rosett, and 242,000 to Lechleider at $10.60 exercise price.
- ·401(k) plan allows contributions up to $23,500 in 2025 with 100% company match on first 3% of compensation.
- ·Target bonus percentages: 60% of base for Siegall, 40% for Rosett and Lechleider.
- ·Corporate performance categories achieved or exceeded: Development/CMC (60%, exceeded), Research (15%, exceeded), Operations/Finance/Admin (12.5%, achieved), Business Development (7.5%, achieved), Commercial (5%, achieved), Stretch Goals (exceeded).
24-04-2026
Alphabet Inc.'s 2026 Definitive Proxy Statement (DEF 14A) details the virtual Annual Meeting of Shareholders on June 5, 2026, for shareholders of record as of April 6, 2026, including election of 10 director nominees, ratification of Ernst & Young LLP as auditors for FY 2026, approval of amending the 2021 Stock Plan to add 200,000,000 Class C shares, and an advisory vote on NEO compensation, with the Board recommending FOR on company proposals and AGAINST shareholder proposals. The statement highlights 2025 achievements such as the Gemini 3 model launch, Ironwood TPU rollout, and establishment of a new Risk & Compliance Committee for enhanced oversight amid AI growth. No performance declines or flat metrics are mentioned.
- ·Annual Meeting voting methods: online at www.proxyvote.com, telephone 1-800-690-6903, mail, or during meeting at www.virtualshareholdermeeting.com/GOOGL26.
- ·Proxy materials available online under 'notice and access' rules; 2025 Annual Report (Form 10-K) accessible at https://abc.xyz/investor/annual-meeting/.
- ·New Risk & Compliance Committee established in October 2025 to focus on regulatory and operational risks.
24-04-2026
Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 24, 2026, announcing the issuance of a press release titled 'AITX's RAD Wins 16 Unit ROSA Order for Multi-Site Construction Deployment.' The press release, attached as Exhibit 99.1, highlights a new order for 16 ROSA units from RAD for deployment across multiple construction sites, signaling demand for AITX's AI security solutions.
- ·Filing under Items 8.01 (Other Events) and 9.01 (Exhibits)
- ·Information furnished, not filed, per Item 8.01
24-04-2026
Intel reported Q1 2026 net revenue of $13,577 million, up 7.2% YoY from $12,667 million, driven by Intel Products (+8.7% to $12,779 million, with DCAI +22.5%) and Intel Foundry (+16.2% to $5,421 million); however, restructuring charges of $4,070 million resulted in an operating loss of $3,136 million (vs. $301 million loss prior year) and net loss attributable to Intel of $3,728 million (vs. $821 million). Gross profit improved 14.5% to $5,347 million amid higher revenue, while operating cash flow rose to $1,096 million from $813 million.
- ·Total assets decreased to $205,332 million from $211,429 million QoQ.
- ·Cash, cash equivalents, and restricted cash increased to $17,695 million from $14,712 million YoY.
- ·Additions to property, plant, and equipment were $3,636 million in investing activities.
- ·Non-controlling interests net income (loss) of $(553) million.
24-04-2026
Muzinich & Co., Inc. disclosed its 13F-HR holdings as of March 31, 2026, reporting a total portfolio value of $285,895,993 across 38 positions, primarily in Business Development Companies (BDCs) and REITs. Top holdings include Ares Capital Corp at $40,011,602 (2,220,399 shares), Blackstone Secured Lending Fund at $28,153,527 (1,188,414 shares), and Blue Owl Capital Corporation at $27,302,130 (2,468,547 shares). The portfolio shows concentration in income-focused securities with sole investment discretion and predominantly sole voting authority.
- ·Other notable holdings include Hercules Capital Inc ($19,941,346, 1,350,125 shares), FS KKR Capital Corp ($8,712,491, 855,844 shares), and Goldman Sachs BDC Inc ($7,117,613, 801,533 shares).
- ·All positions reported as sole investment discretion with voting authority primarily sole (e.g., Ares Capital sole voting 1,706,211 shares).
24-04-2026
Acadia Pharmaceuticals Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 29, 2026 at 8:00 a.m. PT. Proposals include electing three Class I directors to serve until the 2029 annual meeting, advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as independent auditors for FY 2026, and approval of an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 5,209,670. The record date is April 14, 2026, with 171,215,262 shares of common stock outstanding.
- ·Virtual meeting access: meetnow.global/MGYT5K7; login from 7:45 a.m. PT on May 29, 2026.
- ·Proxy materials mailed on or about April 28, 2026.
- ·Legal proxy registration deadline: 5:00 p.m. ET on May 26, 2026.
24-04-2026
Blue Moon Metals Inc. reported total assets of $254,098,193 as of December 31, 2025, a 685% increase from $32,372,944 in 2024, driven by acquisitions of Nussir ($89,940,936 for 93.55% share), NSG ($20,148,644 net), and REAS, alongside $109,489,871 in net financing proceeds that boosted cash to $92,811,289. However, the company posted a net loss of $38,772,860 in 2025 versus $495,756 in 2024, with general exploration expenses surging to $32,679,617 from $448,762, leading to $29,569,179 cash used in operations. Shareholders' equity expanded to $225,007,768 from $4,456,786, but loss per share rose to $0.72 from $0.14 amid share count growth to 80,867,521.
- ·Cash used in investing activities $17,519,094 in 2025 primarily for acquisitions.
- ·Weighted average shares outstanding 51,778,782 in 2025 vs 3,575,832 in 2024.
- ·Non-controlling interest $4,347,210 as of Dec 31 2025.
- ·Debt and lease liabilities $15,643,080 total (current + non-current) as of Dec 31 2025.
24-04-2026
Charter Communications reported Q1 2026 revenues of $13,597 down 1.0% YoY from $13,735, with declines in video revenue (-9.1% to $3,252) and residential internet (-1.3% to $5,852), though mobile service grew 15.1% to $1,052 and advertising sales rose 5.3% to $358. Net income attributable to shareholders decreased 4.5% to $1,163 from $1,217, but basic EPS increased 7.9% to $9.27 due to share repurchases reducing shares outstanding; operating cash flow rose 1.6% to $4,304.
- ·Total assets increased to $154,644M from $154,213M at year-end 2025.
- ·Long-term debt rose to $94,414M from $94,006M.
- ·Cash and cash equivalents up to $517M from $477M.
- ·Shareholders' equity for Charter increased to $16,385M from $16,054M.
24-04-2026
Immunome, Inc. (IMNM) filed a DEFA14A Definitive Additional Materials proxy statement on April 24, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as Definitive Additional Materials by the registrant. No substantive financial or operational details are provided in the filing header.
24-04-2026
Lyell Immunopharma, Inc. (LYEL) filed a DEFA14A Definitive Proxy Statement on April 24, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No specific proposals, financial data, or additional details are provided in the filing header.
24-04-2026
Semus Wealth Partners LLC, managed by CEO Helen Semus, disclosed total holdings of $178,988,130 across 111 positions as of March 31, 2026, in its 13F-HR filing submitted April 24, 2026. Top holdings include Apple Inc. ($34,738,361), Alphabet Inc. Class A ($6,809,859) and Class C ($5,327,127), Microsoft Corp. ($6,264,587), and NVIDIA Corporation ($7,475,373), with all positions held as sole voting power and no reported options or shared power. The portfolio features a mix of individual equities and ETFs focused on large-cap, growth, dividend, and thematic strategies.
- ·All holdings reported with sole voting power (SH SOLE) and no shared voting or investment power.
- ·Firm address: 150 E Palmetto Park Road, Penthouse Suite 800, Boca Raton, FL 33432.
- ·SEC file number: 028-22849; CIK: 0001964775.
24-04-2026
Lyell Immunopharma, Inc. issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 10, 2026 at 8:00 a.m. PT, with a record date of April 14, 2026. Stockholders are asked to vote on electing three Class II directors for three-year terms, ratifying Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, and approving on an advisory basis the compensation of named executive officers. As of the record date, 23,332,524 shares of common stock were outstanding and entitled to vote.
- ·Annual Meeting accessible via live webcast at www.virtualshareholdermeeting.com/LYEL2026; login starts at 7:45 a.m. PT.
- ·Proxy materials notice mailed on or about April 24, 2026.
- ·Voting standards: Plurality for director election; majority of votes cast (excluding abstentions and broker non-votes) for Proposals 2 and 3.
24-04-2026
Altimmune, Inc. entered into an underwriting agreement on April 22, 2026, with Leerink Partners LLC and Barclays Capital Inc. to issue and sell 64,250,000 shares of common stock at $3.00 per share and pre-funded warrants to purchase up to 10,750,000 shares at $2.999 per warrant, each accompanied by common stock warrants. The offering closed on April 24, 2026, generating net proceeds of approximately $211.2 million, which will fund the clinical development of pemvidutide including its global pivotal Phase 3 trial in MASH, pre-commercial activities, and general corporate purposes. No declines or flat performance metrics were reported.
- ·Common stock warrants exercisable until the earlier of fifth anniversary or 45 days after Phase 3 pemvidutide MASH trial data readout.
- ·Pre-funded warrants do not expire and are exercisable immediately subject to ownership limits.
- ·Offering conducted under registration statements File Nos. 333-291329 (effective Dec 5, 2025), 333-285355 (effective Mar 13, 2025), and 333-295254 (effective Apr 22, 2026).
24-04-2026
Comcast reported robust 2025 consolidated financial results with revenue of $123.7 billion, net income of $20.0 billion, and Adjusted EBITDA of $37.4 billion, while returning $11.7 billion to shareholders via $6.8 billion in share repurchases and $4.9 billion in dividends, reducing shares outstanding by 5%. Key segments showed growth including connectivity revenue up 4.2% to $46.0 billion, Peacock revenue increasing 10% to $5.4 billion with paid subscribers up 22% to 44 million and Adjusted EBITDA losses improved by nearly $700 million, and theme parks Adjusted EBITDA of $3.1 billion; business services revenue reached $10.2 billion. The company completed the tax-free spin-off of Versant Media Group in January 2026 and announced leadership changes with Mike Cavanagh promoted to Co-CEO and Gordon Smith joining the Board.
- ·Domestic wireless achieved 1.5 million net line additions in 2025, surpassing 15% penetration of domestic residential broadband customers.
- ·Comcast generated highest free cash flow in company history in 2025.
24-04-2026
Federal Home Loan Bank of San Francisco reported Q1 2026 net income of $64 million, down $30 million or 32% YoY from $94 million, due to a $23 million drop in non-interest income and a $17 million increase in voluntary housing contributions despite slightly lower net interest income of $140 million (vs $142 million). Total assets fell to $70.7 billion from $73.3 billion at December 31, 2025, driven by a $1.9 billion reduction in short-term investments. Positively, the Bank paid a $75 million special dividend, declared quarterly dividends at annualized rates of 4.75% to 10.00%, and maintained a strong regulatory capital ratio of 10.22%.
- ·Non-interest expense increased $9 million YoY to $47 million, driven by $17 million higher voluntary contributions offset by $8 million lower operating expenses.
- ·Provision for credit losses was $0 in Q1 2026 vs $1 million in Q1 2025.
- ·Dividends declared on April 23, 2026, payable May 8, 2026, including 8.75% annualized on pre-conversion Class B stock.
24-04-2026
Alphabet Inc. filed Definitive Additional Proxy Soliciting Materials (DEFA14A) on April 24, 2026, as part of proxy statement materials under the Securities Exchange Act of 1934. The filing contains header information, company details, and embedded graphics, but no specific financial metrics, performance data, or period-over-period comparisons are discernible from the provided content. No improvements, declines, or flat metrics are reported.
- ·Filing Type: DEFA14A (Definitive Additional Proxy Soliciting Materials)
- ·SEC File Number: 001-37580
- ·Fiscal Year End: December 31
- ·Business Address: 1600 Amphitheatre Parkway, Mountain View, CA 94043
- ·Business Phone: 650-253-0000
- ·EIN: 611767919
- ·State of Incorporation: DE
24-04-2026
On April 24, 2026, Scott Gawel resigned as Corporate Vice President and Chief Accounting Officer of Intel Corporation, effective immediately, to pursue another career opportunity. David A. Zinsner, Executive Vice President and Chief Financial Officer, assumed the principal accounting officer role in addition to his existing duties. No financial impacts or further details on succession were disclosed.
24-04-2026
Keurig Dr Pepper Inc. (KDP) issued a DEFA14A filing as a proxy statement notice for its Annual Meeting of Stockholders on June 16, 2026, for record holders as of April 20, 2026. The meeting agenda includes Proposal 1 to elect nine director nominees, Proposal 2 for advisory approval of executive compensation, Proposal 3 to ratify Deloitte & Touche LLP as independent auditors for fiscal year 2026, and Proposal 4 to approve the Omnibus Stock Incentive Plan of 2026. The Board of Directors recommends a FOR vote on all proposals.
24-04-2026
Keurig Dr Pepper Inc. (KDP) reported strong 2025 performance with net sales growth over 8% in constant currency and Adjusted diluted EPS growth of 7%, alongside pro forma revenue of $27.8B and total net sales approximately $28B following the JDE Peet’s acquisition. The proxy seeks approval for electing nine directors (eight independent), advisory vote on executive compensation, ratification of Deloitte & Touche LLP as auditor, and the 2026 Omnibus Stock Incentive Plan. The company announced leadership enhancements including Rafael Oliveira as CEO of Coffee Operating Unit and plans a tax-free separation into two public companies.
- ·2026 Annual Meeting: June 16, 2026, 11:30 a.m. ET, virtual.
- ·Record Date: April 20, 2026.
- ·Nine director nominees, eight independent.
- ·Board's voting recommendations: FOR all four proposals.
24-04-2026
Comcast Corporation issued Definitive Additional Materials (DEFA14A) for its 2026 Annual Shareholder Meeting on June 10, 2026, held virtually. Key proposals include election of 11 director nominees, ratification of independent auditors (For), advisory vote on executive compensation (For), and a shareholder proposal for an independent board chair (Board recommends Against). No financial metrics or period comparisons are provided in this notice.
- ·Filing date: April 24, 2026
- ·Vote by: June 9, 2026 11:59 PM ET at www.ProxyVote.com
- ·Request proxy materials by: May 27, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
- ·Virtual meeting: June 10, 2026 9:00 a.m. ET at comcast.onlineshareholdermeeting.com
24-04-2026
Intelligent Living Application Group Inc. (ILAG) reported FY2025 revenue of $4,493,572, down 40.1% YoY from $7,506,551 in FY2024, while operating expenses surged to $19,482,836 from $5,182,268, resulting in a significantly widened net loss of $19,347,439 versus $3,690,287 prior year. Total assets declined sharply to $8,482,374 from $14,440,221, with current assets dropping 22.6% to $6,820,115 and current liabilities rising to $3,457,035. Although net cash used in operating activities improved slightly to $2,429,866 from $3,042,081, ongoing losses and liquidity concerns raise substantial doubt about the company's ability to continue as a going concern.
- ·Net cash provided by financing activities in FY2025: $1,797,956, compared to net use of $44,557 in FY2024.
- ·Net cash used in investing activities minimal at $3,304 in FY2025 versus $115,161 in FY2024.
- ·FY2023 revenue: $6,443,357; net loss: $3,501,518.
- ·Risks include tariffs impacting U.S. exports, raw material fluctuations, and potential manufacturing disruptions at Xingfa.
24-04-2026
MultiSensor AI Holdings, Inc. filed a definitive proxy statement for its 2026 Annual Meeting on June 12, 2026, at 10:00 a.m. CT, to elect five directors (Margaret Chu, Stuart V. Flavin III, Daniel Friedberg, David Gow, and Petros Kitsos), ratify Weaver and Tidwell L.L.P. as independent auditors for FY 2026, and approve an amendment to increase shares authorized under the 2023 Incentive Award Plan. The record date is April 14, 2026, with 2,012,293 shares of common stock outstanding, adjusted for a 1-for-40 reverse stock split effective April 13, 2026. No financial performance data or period comparisons are included.
- ·Annual Meeting location: offices of Haynes and Boone, LLP at 1221 McKinney St #4000, Houston, TX 77010.
- ·Company headquarters: 24 Greenway Plaza, Suite 1800, Houston, TX 77046.
- ·Proxy materials available at www.cstproxy.com/multisensorai/2026.
- ·Common stock par value: $0.0001 per share.
24-04-2026
MultiSensor AI Holdings, Inc. issued definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Shareholders on June 12, 2026, at 10:00 AM CT. Key proposals include electing directors Margaret Chu, Stuart V. Flavin III, Daniel Friedberg, David Gow, and Petros Kitsos; ratifying Weaver and Tidwell L.L.P. as independent auditors for the fiscal year ending December 31, 2026; and approving an amendment to the 2023 Incentive Award Plan to increase shares reserved for awards. Proxy materials, including the Annual Report for the year ended December 31, 2025, are available online at https://www.cstproxy.com/multisensorai/2026, with paper requests due by May 29, 2026.
- ·Meeting location: Offices of Haynes and Boone, LLP, 1221 McKinney St. #4000, Houston, TX 77010.
- ·Company address: 24 Greenway Plaza, Suite 1800, Houston, TX 77046.
- ·Voting instructions: Online at http://www.cstproxyvote.com or request paper copy by calling 1-888-266-6791 or via https://www.cstproxy.com/multisensorai/2026.
24-04-2026
Genco Shipping & Trading Ltd rejected Diana Shipping's revised unsolicited acquisition proposal of $23.50 per share (initially $20.60 on Nov 24, revised March 6), determining it undervalues the company below its mean analyst NAV of $25 per share and fails to provide an appropriate control premium, especially amid a strong drybulk market. The Board highlights Q4 2025 multi-year highs in EBITDA and TCE rates, a $0.50 dividend (highest since Q4 2022 and 26th consecutive quarterly), $323 million total dividends ($7.565 per share) over six years, and 247% TSR over five years outperforming S&P 500 (76%) and Diana (53%). Genco urges shareholders to use the WHITE proxy card against Diana's proxy contest to replace the entire Board at the 2026 Annual Meeting.
- ·Preliminary proxy statement filed April 24, 2026, with details on director compensation, CD&A, summary comp table, and security ownership.
- ·Diana nominated six director candidates to replace entire Genco Board.
- ·Genco remains open to good faith engagement upon receipt of an appropriately valued offer.
- ·2026 Annual Meeting date not yet announced.
24-04-2026
Alpha Metallurgical Resources reported preliminary Q1 2026 results with a net loss of $11.0 million ($0.86 per diluted share) and Adjusted EBITDA of $30.0 million, reflecting lower shipments from a month-long terminal outage and elevated costs due to repairs, maintenance, and higher diesel prices. Met segment coal revenues reached $523.5 million on 3.6 million tons sold at $124.39 per ton realization, but cash costs rose to $107.98 per ton, yielding a non-GAAP margin of $16.41 per ton. The company maintained strong liquidity of $476.2 million with minimal debt of $12.2 million and continued share repurchases, spending $17.5 million on 87,000 shares in Q1 under a $1.5 billion program.
- ·Definitive Q1 2026 financial results to be released May 8, 2026, with conference call at 10:00 a.m. ET.
- ·Met segment sales breakdown: Domestic 24% ($137.27/ton), Export Australian indexed 33% ($144.95/ton), Export other 43% ($110.32/ton).
- ·ABL: $184.3 million unused availability, $40.7 million letters of credit outstanding, no borrowings.
- ·Non-GAAP coal margin $16.41 per ton.
24-04-2026
Intuitive Machines, Inc. (LUNR) filed a Definitive Additional Proxy Statement (DEFA14A) on April 24, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required and is categorized as Definitive Additional Materials. No substantive proposals, financial data, or other details are provided in the available content.
24-04-2026
Intuitive Machines' 2026 Proxy Statement details the virtual Annual Meeting on June 4, 2026, for electing two Class III directors and ratifying Grant Thornton LLP as auditors for FY 2026. The filing highlights recent acquisitions: 100% of KinetX on October 1, 2025, boosting employees to 525 by December 31, 2025, and 100% of Lanteris on January 13, 2026, expanding the workforce to approximately 1,695. These moves support the company's Moon-first strategy transitioning from missions to persistent space infrastructure operations.
- ·Record date: April 10, 2026
- ·Annual Meeting: June 4, 2026, 9:00 a.m. CT, virtual at www.virtualshareholdermeeting.com/LUNR2026
- ·Proposals: (1) Elect two Class III directors for three-year terms; (2) Ratify Grant Thornton LLP for fiscal year ending December 31, 2026
- ·Company founded in 2013; headquartered at 13467 Columbia Shuttle Street, Houston, Texas 77059
24-04-2026
ImmuCell Corporation's DEF 14A proxy statement for the 2026 Annual Meeting proposes electing directors, approving executive compensation on an advisory basis, ratifying the 2025 Stock Option and Incentive Plan, amending the Certificate of Incorporation, and ratifying the independent auditors. Key governance updates include the appointment of Paul Olivier te Boekhorst as President and CEO effective November 1, 2025, succeeding Michael F. Brigham who retired after 25 years, with Dr. David S. Tomsche remaining as independent Board Chair since 2013. The Board held 4 regular meetings, 1 special meeting, and 9 unanimous written consents in 2025, with all directors attending at least 75% of meetings; no stockholder proposals or director nominations were timely received.
- ·Stockholder proposals for 2026 Annual Meeting must be received not earlier than March 14, 2026 and not later than April 13, 2026.
- ·Director nominations under advance notice by-laws follow same 60-90 day window prior to first anniversary of prior year's meeting.
- ·All sitting directors attended the 2025 Annual Meeting virtually; current nominees plan to attend 2026 meeting virtually.
- ·Proxy holders may approve adjournment up to 20 days to solicit additional votes if recommended.
- ·Strategy & Technology Committee established in April 2026.
24-04-2026
OptimumBank Holdings, Inc. reported Q1 2026 net income of $4.7 million ($0.39 basic EPS, $0.20 diluted), up $0.8 million YoY from $3.9 million but down from $4.9 million in Q4 2025, driven by $3.8 million YoY net interest income growth to $13.2 million and higher deposits/loans to $1.09 billion each (+17.3%/+13.8% QoQ), though offset by $2.4 million higher noninterest expenses and $0.9 million increased credit loss expense. ROAA declined to 1.56% and ROAE to 15.12% QoQ, with efficiency ratio rising to 53.5% amid expansion. Total assets reached $1.27 billion (+$157.1 million QoQ), supported by strong loan growth in commercial real estate (+$123.7 million) but declines in commercial (-$2.1 million), multi-family (-$2.0 million), and residential real estate (-$0.9 million) loan segments.
- ·Gross charge-offs $44,000, recoveries $41,000, net charge-offs $3,000 in Q1 2026.
- ·FHLB advances $40.0 million at Q1 2026 end, down $10.0 million QoQ.
- ·Ranked #49 out of 3,465 U.S. community banks by S&P Global (top 1.4%).
- ·Annual shareholder meeting and webcast on April 28, 2026 at 10:00am ET.
24-04-2026
Texas Instruments reported Q1 2026 revenue of $4,825 million, up 18.6% YoY from $4,069 million, driven by Analog segment growth of 22.3% to $3,924 million and Embedded Processing up 11.7% to $723 million; however, the Other segment declined 16% to $178 million. Net income increased 31.0% to $1,545 million with diluted EPS of $1.68 (up 31.3%), and operating cash flow surged 79.0% to $1,520 million bolstered by $555 million in CHIPS Act incentives, though R&D expenses remained flat at $510 million.
- ·US revenue represented 37% of total ($1,796 million), Europe/Middle East/Africa 22% ($1,070 million), and China 21% ($1,024 million).
- ·Capital expenditures $676 million in Q1 2026, down from $1,123 million in Q1 2025.
- ·Dividends paid $1,291 million in Q1 2026.
- ·Total stockholders’ equity increased to $16,778 million from $16,273 million QoQ.
24-04-2026
United Community Bank filed its 13F-HR on April 24, 2026, disclosing equity holdings as of March 31, 2026, across 565 positions with a total market value of $299.92 billion. Top holdings by value include Berkshire Hathaway Inc. Del Cl B (57,373 shares valued at $27.49 billion), Apple Inc. (15,674 shares valued at $3.98 billion), and Amazon.com Inc. (10,737 shares valued at $2.24 billion). The filing reports solely owned positions with no indicated changes, puts, or calls.
- ·Filing managed by Alisha Kamadia, contact 305-662-5419, South Miami FL
- ·All positions reported as solely owned (investment discretion code 1) with full voting authority
- ·No put or call options reported across any holdings
24-04-2026
At the 2026 Annual Meeting of Shareholders on April 23, 2026, Muncy Columbia Financial Corporation shareholders elected all four Class 1 director nominees—Robert J. Glunk (1,412,168 for, 131,154 withheld), Willard H. Kile, Jr. (1,444,816 for, 98,505 withheld), Steven H. Shannon (1,443,998 for, 99,324 withheld), and Edwin A. Wenner (1,420,194 for, 123,128 withheld)—with 856,490 broker non-votes across all. Shareholders also ratified the appointment of S.R. Snodgrass P.C. as independent auditors for the year ending December 31, 2026, with 2,322,155 for, 50,426 against, and 27,231 abstain. Management's slide presentation from the meeting is furnished as Exhibit 99.1.
- ·Meeting held on April 23, 2026; filing dated April 24, 2026
- ·Auditor appointment for year ending December 31, 2026
- ·No broker non-votes for auditor ratification
Get daily alerts with 11 investment signals, 7 risk alerts, 8 opportunities and full AI analysis of all 33 filings
More from: Nasdaq 100 Stocks SEC Filings
🇺🇸 More from United States
View all →April 17, 2026
US Pre-Market SEC Filings Roundup — April 17, 2026
US Pre-Market SEC Filings Roundup
April 17, 2026
US Merger & Acquisition SEC Filings — April 17, 2026
US Merger & Acquisition SEC Filings
April 17, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — April 17, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings
April 17, 2026
US Earnings Financial Results SEC Filings — April 17, 2026
US Earnings Financial Results SEC Filings